Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by
5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
51	51 Vir Biotechnology VIR $667M	176% upside 4 price targets	0
52	52 Lexeo Therapeutics LXEO $289M	174% upside 3 price targets	0
53	53 Enanta Pharmaceuticals ENTA $161M	169% upside 4 price targets	0
54	54 Arcturus Therapeutics ARCT $490M	166% upside 5 price targets	0
55	55 Ultragenyx Pharmaceutical RARE $2.77B	164% upside 7 price targets	0
56	56 Janux Therapeutics JANX $1.41B	164% upside 6 price targets	0
57	57 Tyra Biosciences TYRA $648M	161% upside 3 price targets	0
58	58 CervoMed CRVO $67.8M	157% upside 5 price targets	0
59	59 Solid Biosciences SLDB $426M	156% upside 4 price targets	0
60	AARD 60 Aardvark Therapeutics, Inc. Common Stock AARD $238M	155% upside 3 price targets	0
61	61 Immunome IMNM $783M	153% upside 4 price targets	0
62	62 ProKidney PROK $342M	147% upside 4 price targets	0
63	63 Vertical Aerospace EVTL $468M	146% upside 3 price targets	0
64	64 AnaptysBio ANAB $554M	144% upside 3 price targets	0
65	65 Praxis Precision Medicines PRAX $927M	135% upside 3 price targets	0
66	BBOT 66 BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT $855M	132% upside 4 price targets	0
67	67 Savara SVRA $622M	129% upside 4 price targets	0
68	68 Dyne Therapeutics DYN $1.87B	125% upside 9 price targets	0
69	69 ArriVent BioPharma AVBP $710M	118% upside 6 price targets	0
70	70 C4 Therapeutics CCCC $241M	117% upside 3 price targets	0
71	71 Arvinas ARVN $559M	114% upside 4 price targets	0
72	72 Microvision MVIS $355M	112% upside 3 price targets	0
73	73 Legend Biotech LEGN $6.36B	109% upside 6 price targets	0
74	74 NovoCure NVCR $1.42B	106% upside 3 price targets	0
75	75 Getty Images GETY $830M	106% upside 3 price targets	0